Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01546376

Enrollment

100

Registered

2012-03-07

Start date

2009-08-31

Completion date

Unknown

Last updated

2012-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT, To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT

Brief summary

Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .

Interventions

RADIATIONRadiation therapy

External photon beam radiation therapy dosage 4000-7000 CGy

OTHERVenepuncture

Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Age 18-65 years * HIV positive cancer patients * Photon beam RT, conventional fraction \>= 4000 cgy in 4 weeks

Exclusion criteria

* CD4 count \< 200 cell/ml and not received anti retro viral

Countries

Thailand

Contacts

Primary ContactPathomphorn Siraprapasiri, MD

spathomphorm@gmail.com66-89-6662960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026